Skip to main content
Clinical Trials/JPRN-UMIN000009715
JPRN-UMIN000009715
Recruiting
Phase 3

A randomized controlled trial comparing laparoscopic surgery with open surgery in palliative resection of primary tumor in incurable Stage IV colorectal cancer (JCOG1107) - Encore Trial: Trial of <en>doscopic palliative <co>lorectal <re>section for symptomatic unresectable colorectal cancer (JCOG1107)

Japan Clinical Oncology Group (JCOG)0 sites194 target enrollmentJanuary 7, 2013

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
nresectable Stage IV colorectal cancer and a synchronous symptomatic primary tumor
Sponsor
Japan Clinical Oncology Group (JCOG)
Enrollment
194
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 7, 2013
End Date
July 7, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japan Clinical Oncology Group (JCOG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma 2\) Infectious disease to be treated 3\) HBs antigen positive 4\) Body temparature \>\= 38c 5\) Women during pregnancy, possible pregnancy or breast\-feeding 6\) Severe mental disease 7\) Currently treated with systemic steroids 8\) Interstitial pneumonia, pulmonary fibrosis, or severe emphysema 9\) Uncontrollable diabetes mellitus or routine administration of insulin 10\) Uncontrolled hypertension, defined as systolic \>\= 150 and/or diastolic \>\= 100 mmHg 11\) New York Heart Association class III /IV cardiac disease or congestive heart failure that would take medication in order to prevent lethal ventricular arrhythmias 12\) Gastrointestinal fistula, perforation, or abscess within 6 months 13\) Unstable angina pectoris, previous myocardial infarction, or arterial thrombotic event within 6 months 14\) Abdominal aortic aneurysm (\>\= 5cm), thoracic aortic aneurysm (\>\= 6cm), or aortic dissection 15\) Congenital hemorrhagic diathesis, coagulation disorder, or significant episodes of acute bleeding of grade 3 or more according to CTCAE ver.4\.0 within the past 28 days 16\) Episodes of hemoptysis within 28 days

Outcomes

Primary Outcomes

Not specified

Similar Trials